{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T03:42:45Z","timestamp":1789530165952,"version":"build-2803163510"},"reference-count":40,"publisher":"MDPI AG","issue":"20","license":[{"start":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T00:00:00Z","timestamp":1665964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Cancer Research UK","award":["C7923\/A18525"],"award-info":[{"award-number":["C7923\/A18525"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Socioeconomic inequalities in survival from non-Hodgkin lymphoma persist. Comorbidities are more prevalent amongst those in more deprived areas and are associated with diagnostic delay (emergency diagnostic route), which is also associated with poorer survival probability. We aimed to describe the effect of comorbidity on the probability of death mediated by diagnostic route (emergency vs. elective route) amongst patients with diffuse large B-cell (DLBCL) or follicular lymphoma (FL). Methods: We linked the English population-based cancer registry and hospital admission records (2005\u20132013) of patients aged 45\u201399 years. We decomposed the effect of comorbidity on survival into an indirect effect acting through diagnostic route and a direct effect not mediated by diagnostic route. Furthermore, we estimated the proportion of the comorbidity effect on survival mediated by diagnostic route. Results: For both DLBCL (n = 27,379) and FL (n = 14,043), those with any comorbidity, or living in more deprived areas, were more likely to experience diagnostic delay and poorer survival. The indirect effect of comorbidity on mortality through diagnostic route was highest at 12 months since diagnosis (DLBCL: Odds Ratio 1.10 [95% CI 1.07\u20131.13], FL: OR 1.09 [95% CI 1.04\u20131.14]). Within the first 12 months since diagnosis, emergency diagnostic route accounted for 24% (95% CI 17.5\u201329.5) and 16% (95% CI 6.0\u201325.6) of the comorbidity effect on mortality, for DLBCL and FL, respectively. Conclusion: Efforts to reduce diagnostic delay (emergency diagnosis) amongst patients with comorbidity would reduce inequalities in DLBCL and FL survival by 24% and 16%, respectively. Further public health programs and interventions are needed to reduce diagnostic delay amongst lymphoma patients with comorbidities.<\/jats:p>","DOI":"10.3390\/cancers14205082","type":"journal-article","created":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T21:11:51Z","timestamp":1666041111000},"page":"5082","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Mediating Effects of Diagnostic Route on the Comorbidity Gap in Survival of Patients with Diffuse Large B-Cell or Follicular Lymphoma in England"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8502-0056","authenticated-orcid":false,"given":"Matthew","family":"Smith","sequence":"first","affiliation":[{"name":"Inequalities in Cancer Outcomes Network, Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Rachet","sequence":"additional","affiliation":[{"name":"Inequalities in Cancer Outcomes Network, Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6683-5164","authenticated-orcid":false,"given":"Miguel","family":"Luque-Fernandez","sequence":"additional","affiliation":[{"name":"Inequalities in Cancer Outcomes Network, Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK"},{"name":"Department of Statistics and Operations Research, University of Granada, 18071 Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,10,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1038\/sj.bjc.6604605","article-title":"Survival from non-Hodgkin lymphoma in England and Wales up to 2001","volume":"99","author":"Rachet","year":"2008","journal-title":"Br. J. Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/sj.bjc.6605752","article-title":"Socioeconomic inequalities in cancer survival in England after the NHS cancer plan","volume":"103","author":"Rachet","year":"2010","journal-title":"Br. J. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1038\/bjc.2015.94","article-title":"Lymphoma incidence, survival and prevalence 2004\u20132014: Sub-type analyses from the UK\u2019s Haematological Malignancy Research Network","volume":"112","author":"Smith","year":"2015","journal-title":"Br. J. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-016-0155-5","article-title":"How much do tumor stage and treatment explain socioeconomic inequalities in breast cancer survival? Applying causal mediation analysis to population-based data","volume":"31","author":"Li","year":"2016","journal-title":"Eur. J. Epidemiol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Renzi, C., Lyratzopoulos, G., Hamilton, W., Maringe, C., and Rachet, B. (2019). Contrasting effects of comorbidities on emergency colon cancer diagnosis: A longitudinal data-linkage study in England. BMC Health Serv. Res., 19.","DOI":"10.1186\/s12913-019-4075-4"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/s41571-019-0249-6","article-title":"Comorbid chronic diseases and cancer diagnosis: Disease-specific effects and underlying mechanisms","volume":"16","author":"Renzi","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00001648-199203000-00013","article-title":"Identifiability and Exchangeability for Direct and Indirect Effects","volume":"3","author":"Robins","year":"1992","journal-title":"Epidemiology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev-publhealth-032315-021402","article-title":"Mediation Analysis: A Practitioner\u2019s Guide","volume":"37","author":"VanderWeele","year":"2016","journal-title":"Annu. Rev. Public Health"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1093\/ije\/dyt127","article-title":"Mediation analysis in epidemiology: Methods, interpretation and bias","volume":"42","author":"Richiardi","year":"2013","journal-title":"Int. J. Epidemiol."},{"key":"ref_10","unstructured":"(2019, October 04). International Agency for Research on Cancer International Classification of Diseases for Oncology. Available online: http:\/\/codes.iarc.fr\/."},{"key":"ref_11","unstructured":"(2020, March 30). Public Health England National Cancer Registration and Analysis Service, Available online: https:\/\/www.gov.uk\/guidance\/national-cancer-registration-and-analysis-service-ncras#cancer-registration."},{"key":"ref_12","unstructured":"(2019, October 04). NHS Digital Hospital Episode Statistics. Available online: https:\/\/digital.nhs.uk\/data-and-information\/data-tools-and-services\/data-services\/hospital-episode-statistics."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Maringe, C., Fowler, H., Rachet, B., and Luque-Fernandez, M.A. (2017). Reproducibility, reliability and validity of population-based administrative health data for the assessment of cancer non-related comorbidities. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0172814"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J. Chronic Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/bjs.6930","article-title":"Identifying co-morbidity in surgical patients using administrative data with the Royal College of Surgeons Charlson Score","volume":"97","author":"Armitage","year":"2010","journal-title":"Br. J. Surg."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1038\/bjc.2012.408","article-title":"Routes to diagnosis for cancer\u2014Determining the patient journey using multiple routine data sets","volume":"107","author":"McPhail","year":"2012","journal-title":"Br. J. Cancer"},{"key":"ref_17","unstructured":"(2019, October 04). National Health Service: Data dictionary Lower Super Output Area. Available online: https:\/\/www.datadictionary.nhs.uk\/data_dictionary."},{"key":"ref_18","unstructured":"(2019, October 04). English Indices of Multiple Deprivation, Available online: https:\/\/www.gov.uk\/government\/statistics\/english-indices-of-deprivation-2015."},{"key":"ref_19","unstructured":"(2020, March 30). Office for National Statistics Clinical Commissioning Group Population Estimates, Available online: https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/populationandmigration\/populationestimates\/datasets\/clinicalcommissioninggroupmidyearpopulationestimates."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1038\/bjc.2014.424","article-title":"Comparing primary and secondary health-care use between diagnostic routes before a colorectal cancer diagnosis: Cohort study using linked data","volume":"111","author":"Sheringham","year":"2014","journal-title":"Br. J. Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/EDE.0b013e3181c1ea43","article-title":"The hazards of hazard ratios","volume":"21","year":"2010","journal-title":"Epidemiology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1541-0420.2011.01640.x","article-title":"On Estimation in Relative Survival","volume":"68","author":"Janez","year":"2012","journal-title":"Biometrics"},{"key":"ref_23","unstructured":"StataCorp (Stata Statistical Software, 2021). Stata Statistical Software, Version 17."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/1536867X1401400107","article-title":"Net survival estimation with stns","volume":"14","author":"Grzebyk","year":"2014","journal-title":"Stata J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/0270-0255(86)90088-6","article-title":"A new approach to causal inference in mortality studies with a sustained exposure period\u2014Application to control of the healthy worker survivor effect","volume":"7","author":"Robins","year":"1986","journal-title":"Math. Model"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1177\/1536867X1201100401","article-title":"gformula: Estimating causal effects in the presence of time-varying confounding or mediation using the g-computation formula","volume":"11","author":"Daniel","year":"2011","journal-title":"Stata J."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Renzi, C., Lyratzopoulos, G., Card, T., Chu, T.P.C., Macleod, U., and Rachet, B. (2016). Do colorectal cancer patients diagnosed as an emergency differ from non-emergency patients in their consultation patterns and symptoms? A longitudinal data-linkage study in England. Br. J. Cancer, 115.","DOI":"10.1038\/bjc.2016.250"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejca.2017.03.013","article-title":"Emergency admission and survival from aggressive non\u2014Hodgkin lymphoma: A report from the UK\u2019s population-based Haematological Malignancy Research Network","volume":"78","author":"Kane","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/ajh.25789","article-title":"Outcome and determinants of failure to complete primary R-CHOP treatment for reasons other than non-response among patients with diffuse large B-cell lymphoma","volume":"95","author":"Harrysson","year":"2020","journal-title":"Am. J. Hematol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/bjc.2012.423","article-title":"Emergency admissions of cancer as a marker of diagnostic delay","volume":"107","author":"Hamilton","year":"2012","journal-title":"Br. J. Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1038\/bjc.2015.355","article-title":"The impact of patient comorbidity on cancer stage at diagnosis","volume":"113","author":"Gurney","year":"2015","journal-title":"Br. J. Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3322\/caac.21342","article-title":"The impact of comorbidity on cancer and its treatment","volume":"66","author":"Sarfati","year":"2016","journal-title":"CA Cancer J. Clin."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/pubmed\/fdx072","article-title":"Do comorbidities influence help-seeking for cancer alarm symptoms? A population-based survey in England","volume":"40","author":"Salika","year":"2017","journal-title":"J. Public Health"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/s41416-021-01523-6","article-title":"Investigating the inequalities in route to diagnosis amongst patients with diffuse large B-cell or follicular lymphoma in England","volume":"125","author":"Smith","year":"2021","journal-title":"Br. J. Cancer"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.canep.2015.08.015","article-title":"Impact of age and socioeconomic status on treatment and survival from aggressive lymphoma: A UK population-based study of diffuse large B-cell lymphoma","volume":"39","author":"Smith","year":"2015","journal-title":"Cancer Epidemiol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Smith, M.J., Belot, A., Quartagno, M., Fernandez, M.A.L., Bonaventure, A., Gachau, S., Majano, S.B., Rachet, B., and Njagi, E.N. (2021). Excess Mortality by Multimorbidity, Socioeconomic, and Healthcare Factors, amongst Patients Diagnosed with Diffuse Large B-Cell or Follicular Lymphoma in England. Cancers, 13.","DOI":"10.21203\/rs.3.rs-209668\/v1"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Ingleby, F.C., Belot, A., Atherton, I., Baker, M., Elliss-Brookes, L., and Woods, L.M. (2020). Assessment of the concordance between individual-level and area-level measures of socio-economic deprivation in a cancer patient cohort in England and Wales. BMJ Open, 10.","DOI":"10.1136\/bmjopen-2020-041714"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1093\/ije\/dyx015","article-title":"Data Resource Profile: Hospital Episode Statistics Admitted Patient Care (HES APC)","volume":"46","author":"Herbert","year":"2017","journal-title":"Int. J. Epidemiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.jclinepi.2012.02.017","article-title":"Review of methods used to measure comorbidity in cancer populations: No gold standard exists","volume":"65","author":"Sarfati","year":"2012","journal-title":"J. Clin. Epidemiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/MLR.0000000000000471","article-title":"The Best Use of the Charlson Comorbidity Index with Electronic Health Care Database to Predict Mortality","volume":"54","author":"Bannay","year":"2016","journal-title":"Med. Care"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/20\/5082\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:55:57Z","timestamp":1760144157000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/20\/5082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,17]]},"references-count":40,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["cancers14205082"],"URL":"https:\/\/doi.org\/10.3390\/cancers14205082","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,17]]}}}